We recently demonstrated that the two main genetic AMD-risk variants, CFH Y402H and a haplotype of 10q26, curb TSP-1 activation of CD47 that is necessary for homeostatic MP elimination and the resolution of acute inflammation in the subretinal space [4,5]. This evidence concerns the gene THBS1 and age-related macular degeneration.